Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR glasses may soothe anxiety in High-Risk pregnancies

NCT ID NCT07660393

Symptom relief Sponsor: Selcuk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 12, 2026 · Updated 5 times

Summary

This study tests whether watching nature-themed videos through virtual reality glasses can reduce anxiety and distress in pregnant women hospitalized with premature rupture of membranes. 176 women will either receive standard care or watch calming nature videos twice a day for three days. Researchers will measure changes in fetal health anxiety, prenatal distress, and mother-baby bonding.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nature-themed video via Virtual Reality Glasses
What this could lead to
If it works, this could offer a simple, drug-free way to ease anxiety and improve emotional well-being for pregnant women hospitalized with premature rupture of membranes.
What could go wrong
This is a small, early-stage trial with only 176 participants, so results may not apply to everyone. The intervention is brief (5 minutes twice a day for 3 days), and any benefits might be short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 176 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being 18 years of age or older * Being nulliparous * Having a diagnosis of preterm premature rupture of membranes (PPROM) * Being between 24 and 37 weeks of gestation * Having a singleton pregnancy * Being hospitalized in the ward for at least 3 days * Having no visual or hearing impairment * Being communicative and mentally and psychologically healthy * Being able to speak and express oneself in Turkish Exclusion Criteria: * Having an additional diagnosis besides preterm premature rupture of membranes (PPROM) (e.g., preeclampsia, fetal distress, fetal anomalies, gestational diabetes, bleeding, etc.) * Having a chronic disease (e.g., hypertension, diabetes mellitus, thyroid disorders, etc.) * Having conceived through assisted reproductive technologies (ART) * Having any skin infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal health anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

preterm premature rupture of the membranes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fetal health anxiety Prenatal attachment Prenatal distress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Seyhan Çankaya

    RECRUITING

    Konya, 42250, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.